Schistosoma mansoni: a method for inducing resistance to praziquantel using infected Biomphalaria glabrata snails Flávia FB Couto; Paulo Marcos Z Coelho; Neusa Araújo; John R Kusel; Naftale Katz; Liana K Jannotti-Passos; Ana Carolina A Mattos PAGE: 153-157 | DOI: 10.1590/S0074-02762011000200006

Comparative randomised trial of high and conventional doses of praziquantel in the treatment of schistosomiasis mansoni Leonardo C de Queiroz; Sandra C Drummond; Maria Laura M de Matos; Mariana BS Paiva; Thaís S Batista; Ahraby ZM Kansaon; Carlos Maurício de F Antunes; José Roberto Lambertucci PAGE: 445-448 | DOI: 10.1590/S0074-02762010000400015

Spatial distribution of Schistosoma mansoni infection before and after chemotherapy with two praziquantel doses in a community of Pernambuco, Brazil Aline F Galvão; Tereza C Favre; Ricardo JPS Guimarães; Ana PB Pereira; Luciana C Zani; Katariny T Felipe; Ana Lúcia C Domingues; Omar S Carvalho; Constança S Barbosa; Otávio S Pieri PAGE: 555-562 | DOI: 10.1590/S0074-02762010000400035

Activity of praziquantel on in vitro transformed Schistosoma mansoni sporocysts ACA Mattos; JR Kusel; PFP Pimenta; PMZ Coelho PAGE: 283-287 | DOI: 10.1590/S0074-02762006000900044

The effects of drugs, ions, and poly-l-lysine on the excretory system of Schistosoma mansoni JR Kusel; FA Oliveira; M Todd; F Ronketti; SF Lima; ACA Mattos; KT Reis; PMZ Coelho; JA Thornhill; F Ribeiro PAGE: 293-298 | DOI: 10.1590/S0074-02762006000900046

Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni Naglaa Mohamed El-Lakkany; Sayed Hassan Seif el-Din; Abdel-Nasser Abdel-Aal Sabra; Olfat Ali Hammam PAGE: 814-822 | DOI: 10.1590/S0074-02762011000700006

Schistogram changes after administration of antischistosomal drugs in mice at the early phase of Schistosoma mansoni infection Andréa Cássia Simões Vimieiro, Neusa Araújo, Naftale Katz, John Robert Kusel, Paulo Marcos Zech Coelho PAGE: 881-886 | DOI: 10.1590/0074-0276130135

Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa Iran Mendonça da Silva, Roberto Thiengo, Maria José Conceição, Luis Rey, Henrique Leonel Lenzi, Edson Pereira Filho, Paulo César Ribeiro PAGE: 445-449

Altered Response of Strain of Schistosoma mansoni to Oxamniquine and Praziquantel Patrícia Ivana Pires Bonesso-Sabadini, Luiz Cândido de Souza Dias PAGE: 381-385

The Immunopathology of Human Schistosomiasis-III. Immunoglobulin Isotype Profiles and Response to Praziquantel Romelia M Ramírez, Evelia Ceballos, Belkisyolé Alarcón de Noya,Oscar Noya, Nicolás Bianco PAGE: 593-599

BCG and Praziquantel for Schistosomiasis Treatment Luciana de Gouvêa Viana, Yerkes Pereira e Silva, Maria Mônica de Aguiar Garcia, Márcia Nogueira Amorim, Naftale Katz, Ana Lúcia Teles Rabello PAGE: 637

The Impact of Repeated Treatment with Praziquantel of Schistosomiasis in Children Under Six Years of Age Living in an Endemic Area for Schistosoma haematobium Infection T Mduluza, PD Ndhlovu, TM Madziwa, N Midzi, R Zinyama, CMR Turner, SK Chandiwana, N Nyazema, P Hagan PAGE: 157-164

(Ca2+-Mg2+)ATPase in Schistosoma mansoni: Evidence for Heterogeneity and Resistance to Praziquantel VMN Cunha, F Noël PAGE: 181-182

Evidence for Functional Ryanodine Receptors in Schistosoma mansoni and their Putative Role in the Control of Calcium Homeostasis Clm Silva, dl Mendonça-Silva, f Noël PAGE: 269-270

Ultrastructural alterations in Schistosoma mansoni juvenile and adult male worms after in vitro incubation with primaquine Reem Osama A Kamel, Fatma El-Zahraa Anwar Bayaumy PAGE: 247-254 | DOI: 10.1590/0074-02760160324

Cannabinoid receptor-1 antagonism: a new perspective on treating a murine schistosomal liver fibrosis model Yasmine Amr Issa, Samar Nabil El Achy, Rasha Fadly Mady DOI: 10.1590/0074-02760190062